The observed protection against Parkinson’s disease (PD) (26) and insights from human MRI data (57) suggest a potential impact of SLC39A8 on the globus pallidum and substantia nigra, which are critical regions associated with PD (64). Here, SLC39A8 is linked to Parkinson disease.